Farah Nabil and Saleem, M. 2026. First-Line FOLFIRINOX vs Gemcitabine ± Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma: Real-World Treatment Response and Clinicopathologic Predictors from a 2022 Tertiary-Center Cohort. Middle Eastern Cancer and Oncology Journal. 2, 2 (Apr. 2026), 11–17. DOI:https://doi.org/10.61706/MECOJ160191.